These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7422630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D, Shivji S, Turner AR.
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract] [Full Text] [Related]

  • 9. [The current status and problems associated with platelet transfusion].
    Kimura A.
    Rinsho Byori; 1982 Oct; 30(10):1074-80. PubMed ID: 7182580
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Control of thrombocytosis by plateletpheresis using a cell separator.
    Beard ME, Blacklock HA, Varcoe AR.
    N Z Med J; 1980 Feb 27; 91(654):136-8. PubMed ID: 6929973
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
    Akkök CA, Brinch L, Lauritzsen GF, Solheim BG, Kjeldsen-Kragh J.
    Vox Sang; 2007 Jul 27; 93(1):42-8. PubMed ID: 17547564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Indications for labile blood products and the physiology of transfusion in surgery].
    Ozier Y, Mignon A, Rosencher N.
    Transfus Clin Biol; 2005 Jun 27; 12(2):221-5. PubMed ID: 15950892
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of three cross-match techniques to select platelet donors. Lymphocytotoxicity, platelet suspension immunofluorescence test, and enzyme-linked immunosorbent assay.
    Bowen TJ, Berman-Wong E, Dawson D, Herbut B, Smith L, Snider C, Hill L.
    Curr Stud Hematol Blood Transfus; 1986 Jun 27; (52):47-57. PubMed ID: 3516584
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Consensus development summaries. Platelet transfusion therapy. National Institutes of Health.
    Conn Med; 1987 Feb 27; 51(2):105-9. PubMed ID: 3829670
    [No Abstract] [Full Text] [Related]

  • 20. [Blood platelet transfusion in a refractory state--HLA-matched transfusion and high-dose intravenous immunoglobulin].
    Fujii H, Maekawa T, Saji H, Maruya E.
    Rinsho Ketsueki; 1986 Jul 27; 27(7):1268-73. PubMed ID: 3784008
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.